What is Dogwood Therapeutics's exchange offer (note 12)?

Dogwood Therapeutics (DWTX) reported exchange offer (note 12) of $27.61M in Q4 2025.

What does exchange offer (note 12) mean?

Represents the total value of debt or other financial instruments converted into common equity during the reporting period. This activity is often part of a broader exchange offer or debt restructuring strategy designed to improve the balance sheet. It indicates the extent to which creditors have opted to become equity holders, thereby reducing the company's debt burden.

Dogwood Therapeutics DWTX Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

CalAmpCAMP

$0-100%

CenterspaceCSR

$43K-93.9%

Rein Therapeutics, Inc. Common StockRNTX

$0—

Empire State Realty TrustESRT

$5.99M+278%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$28.57M—

Blaize Holdings, Inc. Common StockBZAI

$0-100%

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: Dogwood Therapeutics’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's exchange offer (note 12)?: Dogwood Therapeutics (DWTX) reported exchange offer (note 12) of $27.61M in Q4 2025.
What does exchange offer (note 12) mean?: Represents the total value of debt or other financial instruments converted into common equity during the reporting period. This activity is often part of a broader exchange offer or debt restructuring strategy designed to improve the balance sheet. It indicates the extent to which creditors have opted to become equity holders, thereby reducing the company's debt burden.